- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00794924
Probiotics and Hospital Outcome in the Elderly (PROAGE)
November 19, 2008 updated by: Kaplan-Harzfeld Medical Center
Effects of Commercially Available Probiotics on Hospital Outcome
Probiotics have been shown to reduce the rate of diarrhea and constipation.
The purpose of this study was to investigate if probiotics could improve outcome of hospitalized orthopedic elderly patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The patients were divided into two groups.
One received probiotics for 45 days and the second received placebo.
The patients had a clinical and epidemiological as well as nutritional assessment.
They were followed-up as for their bowel movements, abdominal pain and nosocomial infections and for the incidence of helicobacter pylori and clostridiume difficille diarrhea.
Study Type
Interventional
Enrollment (Actual)
345
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients who were hospitalized in the Department of Geriatric Orthopedic Rehabilitation a week before their enrollment in the study and signed an informed consent.
Exclusion Criteria:
- Known or suspected allergy to any probiotics
- Neutropenia
- Inability to sign an informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Probiotics, VSL#3
Acutely hospitalized elderly patients in a geriatric orthopedic rehabilitation department received commercially available probiotics (VSL#3) for 45 days.
|
one sachet per day, for 45 consecutive days
Other Names:
|
Placebo Comparator: Placebo
Acutely hospitalized elderly patients in a geriatric orthopedic rehabilitation department received placebo sachets for 45 days.
|
one sachet per day, for 45 consecutive days
Other Names:
one sachet per day, for 45 consecutive days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction in Number of Days of Either Constipation or Diarrhea in Comparison to the Control Group
Time Frame: 45 days of measuring the outcome
|
Gastrointestinal motility was assessed by the number of days a patient was constipated or had diarrhea.
|
45 days of measuring the outcome
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Improvement in Nutritional and Immunological Measurements
Time Frame: 45 days
|
45 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hilla Zahroni, MA, Chief dietician
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2004
Primary Completion (Actual)
January 1, 2005
Study Completion (Actual)
January 1, 2005
Study Registration Dates
First Submitted
October 28, 2008
First Submitted That Met QC Criteria
November 19, 2008
First Posted (Estimate)
November 20, 2008
Study Record Updates
Last Update Posted (Estimate)
November 20, 2008
Last Update Submitted That Met QC Criteria
November 19, 2008
Last Verified
November 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Probiotics and elderly
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Constipation
-
usMIMA S.L.CompletedConstipation | Constipation Chronic Idiopathic | Constipation; NeurogenicSpain, United Kingdom
-
Institute of Medical Sciences and SUM HospitalNot yet recruitingFunctional Constipation | Constipation - Functional | Constipation Chronic Idiopathic | Fecal Impaction | Pediatric Functional ConstipationIndia
-
SK Life Science, Inc.CompletedChronic Constipation | Functional ConstipationUnited States
-
AbbVieIronwood Pharmaceuticals, Inc.RecruitingFunctional Constipation (FC) | Chronic Idiopathic Constipation (CIC)United States, United Kingdom, Bulgaria, Netherlands
-
usMIMA S.L.University of York; County Durham and Darlington NHS Foundation TrustNot yet recruitingConstipation | Constipation-predominant Irritable Bowel Syndrome | Constipation - Functional | Constipation Chronic Idiopathic | Constipation; Neurogenic
-
Cairo UniversityUnknownChronic Idiopathic Constipation | Functional ConstipationEgypt
-
ProgenaBiomeRecruitingConstipation | Constipation - Functional | Constipation Chronic Idiopathic | Constipation (Excl Faecal Impaction)United States
-
Pamukkale UniversityRecruiting
-
Shanghai University of Traditional Chinese MedicineLonghua Hospital; Shanghai Municipal Hospital of Traditional Chinese MedicineRecruiting
-
Universidade Nova de LisboaCINTESIS - Center for Health Technology and Services ResearchRecruiting
Clinical Trials on VSL#3
-
Dayton Children's HospitalNational Institutes of Health (NIH)TerminatedIrritable Bowel SyndromeUnited States
-
Policlinico HospitalUnknown
-
University of Maryland, BaltimoreNational Center for Complementary and Integrative Health (NCCIH)Terminated
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Recruiting
-
Bambino Gesù Hospital and Research InstituteCompleted
-
Policlinico HospitalCompleted
-
Beth Israel Deaconess Medical CenterTerminated
-
Federico II UniversityUnknown
-
Elena Pita CalandreFerring Pharmaceuticals; Actial Farmaceutica S.r.l.CompletedFibromyalgia | Gastrointestinal DiseaseSpain
-
Baylor College of MedicineNational Institute of Nursing Research (NINR); University of WashingtonCompletedIrritable Bowel SyndromeUnited States